Article

Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization

Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 11/2009; 106(44):18745-50. DOI: 10.1073/pnas.0903032106
Source: PubMed

ABSTRACT

Cellular and tissue defects associated with insulin resistance are coincident with transcriptional abnormalities and are improved after insulin sensitization with thiazolidinedione (TZD) PPARgamma ligands. We characterized 72 human subjects by relating their clinical phenotypes with functional pathway alterations. We transcriptionally profiled 364 biopsies harvested before and after hyperinsulinemic-euglycemic clamp studies, at baseline and after 3-month TZD treatment. We have identified molecular and functional characteristics of insulin resistant subjects and distinctions between TZD treatment responder and nonresponder subjects. Insulin resistant subjects exhibited alterations in skeletal muscle (e.g., glycolytic flux and intramuscular adipocytes) and adipose tissue (e.g., mitochondrial metabolism and inflammation) that improved relative to TZD-induced insulin sensitization. Pre-TZD treatment expression of MLXIP in muscle and HLA-DRB1 in adipose tissue from insulin resistant subjects was linearly predictive of post-TZD insulin sensitization. We have uniquely characterized coordinated cellular and tissue functional pathways that are characteristic of insulin resistance, TZD-induced insulin sensitization, and potential TZD responsiveness.

Download full-text

Full-text

Available from: Albert Hsiao
  • Source
    • "Valine, leucine, and isoleucine are branch-chain amino acids that are converted into Acyl-CoA derivatives. These are converted into either acetyl-CoA or succinyl-CoA and enter the TCA cycle (Sears et al. 2009). Most of the other significantly downregulated pathways, including fatty acid metabolism , propanoate metabolism, butanoate metabolism, tryptophan metabolism, beta-alanine metabolism, lysine degradation, and glyoxylate and dicarboxylate metabolism, also result in the production of acetyl-CoA and succinyl-CoA that enter the TCA cycle. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bovine mastitis is an inflammation-driven disease of the bovine mammary gland that costs the global dairy industry several billion dollars per annum. Because disease susceptibility is a multi-factorial complex phenotype, an integrative biology approach is required to dissect the molecular networks involved. Here, we report such an approach, using next generation sequencing combined with advanced network and pathway biology methods to simultaneously profile mRNA and miRNA expression at multiple time-points (0, 12, 24, 36 and 48h) in both milk and blood FACS-isolated CD14+ monocytes from animals infected in vivo with Streptococcus uberis. More than 3,700 differentially expressed (DE) genes were identified in milk-isolated monocytes (MIMs), a key immune cell recruited to the site of infection during mastitis. Up-regulated genes were significantly enriched for inflammatory pathways, while down-regulated genes were enriched for non-glycolytic metabolic pathways. Monocyte transcriptional changes in the blood, however, were more subtle but highlighted the impact of this infection systemically. Genes up-regulated in blood-isolated-monocytes (BIMs) showed a significant association with interferon and chemokine signalling. Furthermore, twenty-six miRNAs were differentially expressed in MIMs and three in BIMs. Pathway analysis revealed that predicted targets of down-regulated miRNAs were highly enriched for roles in innate immunity (FDR < 3.4E-8) in particular TLR signalling, while up-regulated miRNAs preferentially targeted genes involved in metabolism. We conclude that during S. uberis infection miRNAs are key amplifiers of monocyte inflammatory response networks and repressors of several metabolic pathways.
    Full-text · Article · Jan 2014 · G3-Genes Genomes Genetics
  • Source
    • "TDP-43 may affect translational control via regulation of splicing and transcription of many mRNAs. The effects of TDP-43 expression on 4E-BP activity may affect translational control and amino acid metabolism (Sears et al. 2009), including leucine and isoleucine, which affect the mTOR pathway (Matsumura et al. 2005;Herningtyas et al. 2008). In the current studies, expression of TDP-43 did not change mTOR activity or P70S 6k phosphorylation 2-week post-injection. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The E3 ubiquitin ligase Parkin plays a central role in the pathogenesis of many neurodegenerative diseases. Parkin promotes specific ubiquitination and affects the localization of TDP-43, which controls the translation of thousands of mRNAs. Here we tested the effects of lentiviral Parkin and TDP-43 expression on amino acid metabolism in the rat motor cortex using high frequency (13) C NMR spectroscopy. TDP-43 expression increased glutamate levels, decreased the levels of other amino acids, including glutamine, aspartate, leucine and isoleucine, and impaired mitochondrial TCA cycle. TDP-43 induced lactate accumulation and altered the balance between excitatory (glutamate) and inhibitory (GABA) neurotransmitters. Parkin restored amino acid levels, neurotransmitter balance and TCA cycle metabolism, rescuing neurons from TDP-43-induced apoptotic death. Furthermore, TDP-43 expression led to an increase in 4E-BP levels, perhaps altering translational control and deregulating amino acid synthesis; while Parkin reversed the effects of TDP-43 on the 4E-BP signaling pathway. Taken together, these data suggest that Parkin may affect TDP-43 localization and mitigate its effects on 4E-BP signaling and loss of amino acid homeostasis. This article is protected by copyright. All rights reserved.
    Full-text · Article · Dec 2013 · Journal of Neurochemistry
  • Source
    • "In querying this integrated gene set, it was clear that the immune response pathway was downregulated in both fat depots of insulin-sensitive compared with insulin-resistant obese individuals, but that the signal was significantly more associated with insulin sensitivity in the omental versus subcutaneous fat (Fig. 2A). To better-qualify this observation, we leveraged a second gene expression data set from a separate cohort that provided relative gene transcription levels in subcutaneous fat from individuals who had undergone thiazoladinedione (TZD) treatment for 3 months (30). TZDs are a class of insulin-sensitizer drug that have been shown to robustly improve HOMA-IR in humans (33). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is associated with insulin resistance, a major risk factor for type 2 diabetes and cardiovascular disease. However, not all obese individuals are insulin-resistant, which confounds our understanding of the mechanistic link between these conditions. We conducted transcriptome analyses on 835 obese subjects with mean BMI of 48.8, on which we have previously reported genetic associations of gene expression. Here, we selected ∼320 nondiabetic (HbA(1c) <7.0) subjects and further stratified the cohort into insulin-resistant versus insulin-sensitive subgroups based on homeostasis model assessment-insulin resistance. An unsupervised informatics analysis revealed that immune response and inflammation-related genes were significantly downregulated in the omental adipose tissue of obese individuals with extreme insulin sensitivity and, to a much lesser extent, in subcutaneous adipose tissue. In contrast, genes related to β-oxidation and the citric acid cycle were relatively overexpressed in adipose of insulin-sensitive patients. These observations were verified by querying an independent cohort of our published dataset of 37 subjects whose subcutaneous adipose tissue was sampled before and after treatment with thiazolidinediones. Whereas the immune response and inflammation pathway genes were downregulated by thiazolidinedione treatment, β-oxidation and citric acid cycle genes were upregulated. This work highlights the critical role that omental adipose inflammatory pathways might play in the pathophysiology of insulin resistance, independent of body weight.
    Full-text · Article · Dec 2012 · Diabetes
Show more